BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11544314)

  • 1. Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: structural insights into Fas/Fas ligand interaction.
    Nisihara T; Ushio Y; Higuchi H; Kayagaki N; Yamaguchi N; Soejima K; Matsuo S; Maeda H; Eda Y; Okumura K; Yagita H
    J Immunol; 2001 Sep; 167(6):3266-75. PubMed ID: 11544314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.
    Mihara S; Suzuki N; Takeba Y; Soejima K; Yamamoto S
    Clin Exp Immunol; 2002 Aug; 129(2):359-69. PubMed ID: 12165095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling.
    Obungu VH; Gelfanova V; Rathnachalam R; Bailey A; Sloan-Lancaster J; Huang L
    Biochemistry; 2009 Aug; 48(30):7251-60. PubMed ID: 19588926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites.
    Fadeel B; Lindberg J; Achour A; Chiodi F
    Int Immunol; 1998 Feb; 10(2):131-40. PubMed ID: 9533440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acid residues important for ligand binding to Fas.
    Starling GC; Bajorath J; Emswiler J; Ledbetter JA; Aruffo A; Kiener PA
    J Exp Med; 1997 Apr; 185(8):1487-92. PubMed ID: 9126929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.
    Starling GC; Kiener PA; Aruffo A; Bajorath J
    Biochemistry; 1998 Mar; 37(11):3723-6. PubMed ID: 9521690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and potential utility of porcine Fas ligand: overexpression in porcine endothelial cells protects them from attack by human cytolytic cells.
    Tsuyuki S; Kono M; Bloom ET
    Xenotransplantation; 2002 Nov; 9(6):410-21. PubMed ID: 12371937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis.
    Runkel L; De Dios C; Karpusas M; Baker D; Li Z; Zafari M; Betzenhauser M; Muldowney C; Miller S; Redlich PN; Grossberg SE; Whitty A; Hochman PS
    J Interferon Cytokine Res; 2001 Nov; 21(11):931-41. PubMed ID: 11747625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate domains of the human fas ligand dictate self-association and receptor binding.
    Orlinick JR; Elkon KB; Chao MV
    J Biol Chem; 1997 Dec; 272(51):32221-9. PubMed ID: 9405425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope Mapping of Neutralizing Monoclonal Antibodies to Human Interferon-γ Using Human-Bovine Interferon-γ Chimeras.
    Zuber B; Rudström K; Ehrnfelt C; Ahlborg N
    J Interferon Cytokine Res; 2016 Sep; 36(9):542-51. PubMed ID: 27336613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of the linear site on the Fas/APO-1 molecule targeted by the prototypic anti-Fas mAb.
    Fadeel B; Thorpe J; Chiodi F
    Int Immunol; 1995 Dec; 7(12):1967-75. PubMed ID: 8746566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
    Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
    J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
    Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
    Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.
    Danilov SM; Watermeyer JM; Balyasnikova IV; Gordon K; Kugaevskaya EV; Elisseeva YE; Albrecht RF; Sturrock ED
    Biochemistry; 2007 Aug; 46(31):9019-31. PubMed ID: 17630779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
    Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
    J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the Anti-Bovine Podoplanin Monoclonal Antibody PMab-44.
    Yamada S; Honma R; Kaneko MK; Nakamura T; Yanaka M; Saidoh N; Takagi M; Konnai S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):129-134. PubMed ID: 28498096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope Mapping of Monoclonal Antibody PMab-52 Against Cat Podoplanin.
    Chang YW; Kaneko MK; Yamada S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):95-99. PubMed ID: 29394131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicity.
    Jodo S; Pidiyar VJ; Xiao S; Furusaki A; Sharma R; Koike T; Ju ST
    J Immunol; 2005 Apr; 174(8):4470-4. PubMed ID: 15814666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment.
    Haruyama H; Ito S; Miyadai K; Takahashi T; Kawaida R; Takayama T; Hanzawa H; Hata T; Yamaguchi J; Yoshida-Kato H; Ichikawa K; Ohsumi J; Yonehara S; Serizawa N
    Biol Pharm Bull; 2002 Dec; 25(12):1537-45. PubMed ID: 12499636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.